ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | ![](/images/54719/135303_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
AHNAK2 | AHNAK nucleoprotein 2 | Cancer-related genes
| | | | ![](/images/20111/47158_B_9_5_rna_selected_60x60.jpg) | Tissue enriched |
AK4 | Adenylate kinase 4 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | ![](/images/42753/94807_A_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
AKR1B1 | Aldo-keto reductase family 1, member B1 (aldose reductase) | Cancer-related genes Enzymes Plasma proteins
| | | | ![](/images/18773/40837_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/29074/65842_A_2_6_rna_selected_60x60.jpg) | Group enriched |
AMPH | Amphiphysin | Cancer-related genes
| | | | ![](/images/8559/22541_B_2_8_rna_selected_60x60.jpg) | Tissue enriched |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/20896/48102_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins
| | | | ![](/images/19918/47053_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | ![](/images/3894/12744_A_8_3_rna_selected_60x60.jpg) | Tissue enriched |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1198/2772_A_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/26624/56299_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CAV1 | Caveolin 1, caveolae protein, 22kDa | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | ![](/images/3791/10084_B_5_5_rna_selected_60x60.jpg) | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1223/5627_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/58574/142433_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | ![](/images/2221/5839_B_9_3_rna_selected_60x60.jpg) | Group enriched |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | ![](/images/10751/28520_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/469/2664_B_6_6_rna_selected_60x60.jpg) | Tissue enhanced |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | ![](/images/10743/26204_B_6_7_rna_selected_60x60.jpg) | Tissue enriched |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | ![](/images/18530/41188_B_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | ![](/images/24961/54941_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
FHL2 | Four and a half LIM domains 2 | | | | | ![](/images/6028/18426_B_8_8_rna_selected_60x60.jpg) | Group enriched |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/11284/26941_A_1_6_rna_selected_60x60.jpg) | Tissue enriched |
HOXB13 | Homeobox B13 | Transcription factors
| | | | ![](/images/4438/19508_B_9_3_rna_selected_60x60.jpg) | Group enriched |
IRF8 | Interferon regulatory factor 8 | Disease related genes Plasma proteins Transcription factors
| | | | ![](/images/2267/7977_A_1_5_rna_selected_60x60.jpg) | Tissue enhanced |
KHDRBS3 | KH domain containing, RNA binding, signal transduction associated 3 | | | | | ![](/images/275/1253_A_2_2_rna_selected_60x60.jpg) | Group enriched |
KLHL41 | Kelch-like family member 41 | Cytoskeleton related proteins Plasma proteins
| | | | ![](/images/21165/48902_A_1_8_rna_selected_60x60.jpg) | Tissue enriched |
KRT13 | Keratin 13 | Cancer-related genes Disease related genes Plasma proteins
| | | | ![](/images/133/2841_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
KYNU | Kynureninase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/31686/67663_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | ![](/images/7891/22296_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
MAP1B | Microtubule-associated protein 1B | Plasma proteins
| | | | ![](/images/22275/50911_A_3_3_rna_selected_60x60.jpg) | Tissue enhanced |
MAP2 | Microtubule-associated protein 2 | FDA approved drug targets Plasma proteins
| | | | ![](/images/1984/5294_A_2_8_rna_selected_60x60.jpg) | Tissue enriched |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | ![](/images/395/142119_B_3_2_rna_selected_60x60.jpg) | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/8855/25361_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | ![](/images/142/2717_A_6_4_rna_selected_60x60.jpg) | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | | | | | ![](/images/18587/40689_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
NES | Nestin | Plasma proteins
| | | | ![](/images/26111/58724_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | ![](/images/56798/136001_A_2_6_rna_selected_60x60.jpg) | Group enriched |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | ![](/images/7308/19162_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | ![](/images/12047/28141_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | ![](/images/51038/137898_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | ![](/images/9257/141347_B_8_4_rna_selected_60x60.jpg) | Group enriched |
PODXL | Podocalyxin-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | ![](/images/62558/140926_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
RIPK2 | Receptor-interacting serine-threonine kinase 2 | Cytoskeleton related proteins Enzymes
| | | | ![](/images/16499/38746_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
S100A14 | S100 calcium binding protein A14 | Plasma proteins
| | | | ![](/images/27613/61675_B_7_3_rna_selected_60x60.jpg) | Tissue enhanced |
SATB2 | SATB homeobox 2 | Disease related genes Transcription factors
| | | | ![](/images/1042/2303_B_7_2_rna_selected_60x60.jpg) | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | ![](/images/1893/5702_A_1_5_rna_selected_60x60.jpg) | Group enriched |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | ![](/images/2759/7040_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | ![](/images/47171/146636_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | ![](/images/3394/10561_B_7_3_rna_selected_60x60.jpg) | Group enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | ![](/images/2226/6002_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |